China's BCI start-ups, seen as potential rivals to Elon Musk's Neuralink, gain momentum as regulatory support and new capital ...

Neuralink’s current trial, named the The PRIME Study, is aimed at providing individuals with quadriplegia the ability to ...

In a world first, China has approved a brain implant for commercial use in people with spinal cord injuries. The device is a type of brain-computer interface (BCI) and is made by the Shanghai-based ...

China has approved its first-ever invasive brain-computer interface product, marking a key regulatory milestone in Chinese startups’ quest to challenge US rivals such as Elon Musk-backed Neuralink ...

Elon Musk’s Neuralink on Monday raised $650M in its latest funding round as its brain implant device enters clinical trials. The Series E round drew participation from ARK Invest, Sequoia Capital, ...

This is the largest early-stage funding in China’s brain computer interface industry.

A groundbreaking brain chip has transformed a paralyzed man’s life, opening new possibilities. Noland Arbaugh, the first person to receive Neuralink’s experimental implant, can now control devices ...

Science Corp., a biotech startup focused on brain-computer interface technologies, announced Thursday that it has closed on a ...

Add Yahoo as a preferred source to see more of our stories on Google. Elon Musk's Neuralink suggests a human patient may have successfully used its brain chip to control a robotic arm. A video posted ...

Paradromics Inc., a neurotechnology company developing a brain-computer interface platform, successfully completed its first human procedure after nearly three years of preclinical studies. The ...

Scientists at Elon Musk-backed Neuralink gave a progress update during a conference streamed online from the company's headquarters in Fremont, California. This came just over a year after Neuralink, ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. The first human patient to reportedly receive Neuralink’s ...